Name and surname:
|
prof. MUDr. Fedor Šimko, CSc.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
University teacher (PhD student, assistent, associate professor, professor) | Comenius University in Bratislava, Faculty of Medicine | 1982 - till present |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
certifications in internal medicine | Faculty of Medicine / SZU | 1988 |
certification of cardiology | Faculty of Medicine / SZU | 1996 |
JASPEX - language and social certification for foreign experts | Comenius University in Bratislava | 1988 |
Certification in pedagogical skills | Comenius University in Bratislava | 1987 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
pathological physiology 1+2 v in both Slovak and English language | general medicine | II | general medicine |
pathological physiology 1+2 v in both Slovak and English language | dentistry | II | dentistry |
Introduction into research activities | all the PhD. programmes at the Faculty of Medicine in Bratislava | III | general medicine and dentistry |
The most important syndromes in pathophysiology | general medicine | II | general medicine |
V.2.a - Name of the study programme | V.2.b - Degree | V.2.c - Field of study |
---|---|---|
Normal and pathological physiology | III | general medicine |
V.3.a - Name of the field of habilitation procedure and inaugural procedure | V.3.b - Study field to which it is assigned |
---|---|
Normal and pathologic physiology - habilitation procedure | general medicine |
Normal and pathologic physiology - inauguration procedure | general medicine |
V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
---|---|---|---|
Pathophysiology | general medicine and dentistry | II | general medicine and dentistry |
The most important syndromes in pathophysiology | general medicine | II | general medicine |
Simko F, Baka T, Paulis L, Reiter RJ. Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review.
J Pineal Res. 2016 Sep;61(2):127-37. Q1 IF=10,3
Simko F, Bednarova KR, Krajcirovicova K, Hrenak J, Celec P, Kamodyova N, Gajdosechova L, Zorad S, Adamcova M. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure.
J Pineal Res. 2014;57(2):177-84. Q1 IF=9,6 Q1
Simko F, Stanko P, Repova K, Baka T, Krajcirovicova K, Aziriova S, Domenig O, Zorad S, Adamcova M, Paulis L Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system.
Biomed Pharmacother. 2024;173:116391. doi: 10.1016/j.biopha. Q1 IF=7,5 Q1
Simko F, Pechanova O. Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment.
J Pineal Res. 2009;47:127-33. Q1 IF=5,45
Simko, F., Pechanova, O., Pelouch, V.,Krajcirovicova, K., Mullerova, M.,Bednarova, K., Adamcova, M., Paulis, L. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. 2009 J Hypertens 2009, 27 (Supl. 6) , S5-S10 Q1 IF=4,99
Simko F, Stanko P, Repova K, Baka T, Krajcirovicova K, Aziriova S, Domenig O, Zorad S, Adamcova M, Paulis L Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system. Biomed Pharmacother. 2024;173:116391. doi: 10.1016/j.biopha. Q1 IF=7.5
Simko F, Baka T. Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells. Front Pharmacol. 2022, 13:842512. Q1 IF=6.2
Simko F, Hrenak J, Adamcova M, Paulis Ľ.Renin-angiotensin-aldosterone system: Friend or foe-the matter of balance. Insight on history, therapeutic implications andcovid-19 interactions. Int J Mol Sci. 2021, 22(6):1-8. 2021: Q1 IF=6.2
Repova K, Aziriova S, Krajcirovicova K, Simko F. Cardiovascular therapeutics: A new potential for anxiety treatment? Med Res Rev. 2022 42(3):1202-1245. Q1 IF=13.2
Mukherjee, D. - Ghosh, A.K. - Dutta, M. - Mitra, E. - Mallick, S. - Saha, B. - Reiter, R.J. - Bandyopadhyay, D.: Journal of Pineal Research, vol. 58, no. 3, 2015, s. 275-290 -- SCI ; SCOPUS
Xie, S. - Deng, Y. - Pan, Y.Y. - Wang, Z.H. - Ren, J. - Guo, X.L. - Yuan, X. - Shang, J. - Liu, H.G.: Biochemical and Biophysical Research Communications, vol. 464, no. 4, 2015, s. 975-981 -- SCI ; SCOPUSMaarman, G. - Blackhurst, D. - Thienemann, F. - Blauwet, L. - Butrous, G. - Davies, N. - Sliwa, K. - Lecour, S.: Journal of Pineal Research, vol. 59, no. 3, 2015, s. 343-353 -- SCI ; SCOPUSHu, W. - Ma, Z. - Jiang, S. - Fan, C. - Deng, C. - Yan, X. - Di, S. - Lv, J. - Reiter, R.J. - Yang, Y.: Journal of Pineal Research, vol. 60, no. 2, 2016, s. 121-131 -- SCI ; SCOPUSHe, B. - Zhao, Y.C. - Gao, L.C. - Ying, X.Y. - Xu, L.W. - Su, Y.Y. - Ji, Q.Q. - Lin, N. - Pu, J.: Hypertension, vol. 67, no. 6, 2016, s. 1237-1248 -- SCI ; SCOPUSSimko F, Baka T, Paulis L, Reiter RJ.Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review. J Pineal Res. 2016 Sep;61(2):127-37.
Ovali, M.A. - Uzun, M.: Cellular and Molecular Biology, vol. 63, no. 3, 2017, s. 45-50 -- SCI ; SCOPUSBaltatu, O.C. - Amaral, F.G. - Campos, L.A. - Cipolla-Neto, J.: Cellular and Molecular Life Sciences, vol. 74, no. 21, 2017, s. 3955-3964 -- SCI ; SCOPUSZhang, Y. - Liu, X. - Bai, X. - Lin, Y. - Li, Z. - Fu, J. - Li, M. - Zhao, T. - Yang, H. - Xu, R. - Li, J. - Ju, J. - Cai, B. - Xu, C. - Yang, B.: Journal of Pineal Research, vol. 64, no. 2, 2018, art. no. e12449 -- SCI ; SCOPUSDing, M. - Feng, N. - Tang, D. - Feng, J. - Li, Z. - Jia, M. - Liu, Z. - Gu, X. - Wang, Y. - Fu, F. - Pei, J.: Journal of Pineal Research, vol. 65, no. 2, 2018, art. no. e12491 -- SCI ; SCOPUSCipolla-Neto, J. - do Amaral, F.G.: Endocrie Reviews, vol. 39, no. 6, 2018, s. 990-1028 -- SCI ; SCOPUSSimko, F.; Hrenak, J.; Adamcova, M.; Paulis, L. Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions. Int.J.Mol.Sci. 2021, 22,3217.
Parn, Kim Wai, et al. "Safety and efficacy of dietary epigallocatechin gallate supplementation in attenuating hypertension via its modulatory activities on the intrarenal renin–angiotensin system in spontaneously hypertensive rats." Nutrients 14.21 (2022): 4605.Borsche, Lorenz, Bernd Glauner, and Julian von Mendel. "COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/mL 25 (OH) D3: results of a systematic review and meta-analysis." Nutrients 13.10 (2021): 3596.Xie, J-X., et al. "The function of the ACE2/Ang (1-7)/Mas receptor axis of the renin-angiotensin system in myocardial ischemia reperfusion injury." European Review for Medical & Pharmacological Sciences 26.6 (2022).Esmaeilzadeh, Abdolreza, et al. "Endocrine and metabolic complications of COVID-19: lessons learned and future prospects." Journal of Molecular Endocrinology 69.3 (2022): R125-R150.Cojocaru, Elena, et al. "Role of the renin-angiotensin system in long COVID’s cardiovascular injuries." Biomedicines 11.7 (2023): 2004.Repova K, Aziriova S, Krajcirovicova K, Simko F. Cardiovascular therapeutics: A new potential for anxiety treatment? Med Res Rev. 2022 May;42(3):1202-1245.
Pereira, AT; Gelfuso, ÉA and Beleboni, RO Repositioning pinacidil and its anticonvulsant and anxiolytic properties in murine models SCIENTIFIC REPORTS 14 (1)Chen, ZY; Tang, YC; (...); Feng, TY Edge-centric connectome-genetic markers of bridging factor to comorbidity between depression and anxiety NATURE COMMUNICATIONSarrow_drop_down 15 (1)Saba, L; Maindarkar, M; (...); Suri, JS A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool FRONTIERS IN BIOSCIENCE-LANDMARKarrow 28 (10)Manolis, TA; Manolis, AA; (...); Manolis, AS Neuropsychiatric disorders in patients with heart failure: not to be ignored HEART FAILURE REVIEWS 28 (4) , pp.821-858Woodman, R; Student, J; (...); Lockette, W Ivabradine-Induced Bradycardia is Accompanied by Reduced Stress-Related AnxietyAMERICAN JOURNAL OF HYPERTENSION36 (6) , pp.316-323Simko F, Baka T. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? Clin Sci (Lond). 2021 Apr 30;135(8):1009-1014.
Daher J. Endothelial dysfunction and COVID-19 (Review). Biomed Rep. 2021 Dec;15(6):102. doi: 10.3892/br.2021.1478. Epub 2021 Oct 7. PMID: 34667599; PMCID: PMC8517756.Calò LA, Stefanelli LF, Nalesso F. Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence. Kidney Blood Press Res. 2022;47(10):593-596. Calò LA, Stefanelli LF, Nalesso F. Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence. Kidney Blood Press Res. 2022;47(10):593-596. doi: 10.1159/000526791.Dayaramani C, De Leon J, Reiss AB. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina (Kaunas). 2021 Aug 17;57(8):833.Cardiovascular protection in experimental hypertension and heart failure by dual inhibition of neprilysin and at1 receptors for angiotensin II: comparison with ACE inhibition and melatonin
Principal investigator: F. Šimko
Project start year: 2019; Project end year: 2022
VEGA 2/0112/19
Experimental myocardial infarction: contribution of hypertension and obesity, effect of toll-like receptor inhibitor
Principal investigator: O.Pecháňová, F. Šimko
Project start year: 2019; Project end year: 2022
VEGA 1/0048/23
Protection of the cardiovascular system in experimental hypertension and heart failure by the sodium-glucose cotransporter 2 inhibitor dapagliflozin: effect on the heart, blood vessels and kidneys. Comparison with the ace-inhibitor captopril
Principal investigator: F. Šimko
Project start year: 2023; Project end year: 2026
VEGA 2/0025/23
ACE2 receptor inhibition in hypertension and obesity as a potential model of the consequences of covid-19: the effect of s-nitrosocaptopril
Principal investigator: O. Pecháňová, F. Šimko,
Project start year: 2023; Project end year: 2026
APP-COVID-20-0043
New perspectives in the treatment of cardiovascular complications associated with COVID-19
Principal investigator: S. Čačániová, co-investigator: F. Šimko
Project start year: 2020; Project end year: 2021
APVV-20-0421
Cardiometabolic effects of Mas receptor stimulation by modulating the renin-angiotensin system - the key role of angiotensin-converting enzyme 2
Principal investigator: Š. Zorád, co-investigator: F. Šimko
Project start year: 2021; Project end year: 2024
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
main guarantor of the study subject Normal and pathological physiology - doctoral, habilitation, inaugural proceedings | Faculty of Medicine, Comenius University | 2007 - till present |
vice-dean for science and research | Faculty of Medicine, Comenius University | 2007 - 2011 |
member of the Approbation committee of the Faculty of Medicine | Faculty of Medicine, Comenius University | 2023 - till present |
Co-Editor-in-Chief of the journal Bratislava Medical Journal | Faculty of Medicine, Comenius University | 2015 - 2022 |
member of the editorial board of the journal Journal of Hypertension | journal Journal of Hypertension | 2010-2013 |
member of the editorial board of the journal World J Hypertension | journal World J Hypertension | 2015-till presence |
member of the editorial board of the journal Reports | journal Reports | 2021- till present |
member of the committee of the Slovak Society of Cardiology | the Slovak Society of Cardiology | 2008-2020 |
member of the committee of the Slovak Society of Hypertension | the Slovak Society of Hypertension | 2021 - till present |
Member of the Presidium of the Scientific Council of the Ministry of Health of the Slovak Republic | Ministry of Health of the Slovak Republic | 2004 - 2011 |
VIII.a - Name of the institution | VIII.b - Address of the institution | VIII.c - Duration (indicate the duration of stay) | VIII.d - Mobility scheme, employment contract, other (describe) |
---|---|---|---|
Berlín-Buch - (German Academy of Sciences) | German Academy of Sciences | 1988 - one month | study stay Prof. Wallukat |
the Clinic of internal medicine Prague-Motol | Prague-Motol hospital | 1991 - 1 month | study stay Prof. Fischerová |
Unispital Zurich - echocardiographic department | Zurich - Switzerland | 1992 - two months | study stay - echocardiography Prof. Jeni |
Institut Physiologie, Medizinische Fakultät, Gottingen | Gottingen - Germany | 1992-1994 - 18 months | Foundation Alexander von Humboldt Stifftung - prof. Bretschneider |
Heidelberg - Institut Experimentelle Chirurgie | Heidelberg - Germany | 2000 - two months | Foundation Alexander von Humboldt Stifftung - prof. Gebhard |
Unispital Wien - Abt. Echokardiogrphie | Wienna | 1991 - two months | study stay - training in echocardiography |
domestic awards:
Scientist of the Year of the Slovak Republic 2008
Award for Science and Technology 2023 in the category Personality of Science and Technology
Honorary Award of Academician T.R. Niederlanda Presidium SLS 2024
Final nomination for the Crystal Wing 2009
Guoth Prize of the Presidium SLS 1988
Jesseni Prize of the Presidium SLS 2016
2016 - Hynek Medal of the Faculty of Medicine, University of Prague
1981 - Rector's Award for Excellent Academic Achievements
2x Rector's Award of the Comenius University for the Best Publication and Scripts
8x awards of the professional societies of the Slovak University of Cardiology (Hypertension, Physiology, Internal Medicine) for the best publications of the year
2011 - Dean's Award as the best trainer within the Slovak Society of Cardiology in the last 10 years
Honorary membership of the Slovak Cardiological Society 2016
Honorary membership of the Slovak Pathophysiological Society 2016
Honorary membership of the Slovak Hypertension Society 2021
Purkinje Lecture of the Slovak Physiological Society 2008
Rector's Lecture of the Comenius University 2008
Haviar's lecture of the Slovak Society of Cardiology 2010
foreign awards:
Prestigious scholarship: Alexander von Humboldt Fellowship 1992-1994, 2000,
FESC title from the European Society of Cardiology
1996 - most cited paper in Physiol Res in the last 10 years
1999 - Medical Education Center of Pennsylvania - request for rights to use the publication Simko F, Simko J: Heart failure and angiotensin converting enzyme inhibition: problems and perspectives. Phys Res 48,1-8:1999 for the purpose of teaching American doctors
Šimko F, Paulis L: Melatonin as a potential antihypertensive treatment.J Pineal Res 42:319-322,2007 - on the web the 5th most read paper of the given journal in 2007.
5x guest editor:
-Guest editor: F. Simko Physiological Research 2007: The importance of nitric oxide in the haemodynamically overloaded circulation IF=2.12
-Guest editor: F. Simko, O. Pechanova : J Hypertension 27, Suppl 6,1-52, 2009. : "Recent trends in hypertension treatment: perspectives from animal studies" IF=4.99
-Guest editor: F. Simko, O. Pechanova : J Hypertension 28, Suppl 1, 1-62, 2010. "Remodelling of heart and vessels in experimental hypertension: advances in protection". – IF=4.5
- Guest editor: F Simko, L Paulis, RJ Reiter Frontiers in Bioscience: The protective role of melatonin in the cardiovascular system. IF-4.02
-Guest editor: M Adamcova, F. Simko, L. Paulis: Int J Mol Sci 2021: Renin-angiotensin-aldosterone system: the friend or enemy: the matter of balance. IF = 6.2
Editorial board member of J Hypertens, World J Hypertens, Frontiers in Bioscience, Bratisl Med J, Cardiol Lett., Reports
Reviewer of 35 pending journals including Lancet, Circulation, Circulation Res.